Marit J. van Gils

16.6k total citations · 2 hit papers
123 papers, 3.8k citations indexed

About

Marit J. van Gils is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Marit J. van Gils has authored 123 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Infectious Diseases, 57 papers in Virology and 41 papers in Immunology. Recurrent topics in Marit J. van Gils's work include HIV Research and Treatment (57 papers), SARS-CoV-2 and COVID-19 Research (36 papers) and Monoclonal and Polyclonal Antibodies Research (35 papers). Marit J. van Gils is often cited by papers focused on HIV Research and Treatment (57 papers), SARS-CoV-2 and COVID-19 Research (36 papers) and Monoclonal and Polyclonal Antibodies Research (35 papers). Marit J. van Gils collaborates with scholars based in Netherlands, United States and United Kingdom. Marit J. van Gils's co-authors include Rogier W. Sanders, Andrew B. Ward, Ian A. Wilson, John P. Moore, Hanneke Schuitemaker, Dennis R. Burton, Jean‐Philippe Julien, Albert Cupo, Terri Wrin and Zelda Euler and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Marit J. van Gils

119 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

2013 629 citations Rogier W. Sanders, Jean‐Philippe Julien et al. PLoS Pathogens profile →
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

2021 196 citations Meng Yuan, Deli Huang et al. Science profile →

Peers

Countries citing papers authored by Marit J. van Gils

Since Specialization

Citations

This map shows the geographic impact of Marit J. van Gils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit J. van Gils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit J. van Gils more than expected).

Fields of papers citing papers by Marit J. van Gils

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit J. van Gils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit J. van Gils. The network helps show where Marit J. van Gils may publish in the future.

Co-authorship network of co-authors of Marit J. van Gils

This figure shows the co-authorship network connecting the top 25 collaborators of Marit J. van Gils. A scholar is included among the top collaborators of Marit J. van Gils based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marit J. van Gils. Marit J. van Gils is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anellovirus constraint from 2 to 6 months postpartum followed by betatorquevirus and gammatorquevirus dominance in serum and milk 2025 ·Journal of Virology ·(unknown), (unknown), Martin Deijs, Jacqueline van Rijswijk, Marit J. van Gils, Johannes B. van Goudoever, Britt J. van Keulen, Lia van der Hoek	0
2	Innovative Single-Cell Sequencing Techniques for B cell Analysis and Their Implications for Rational HIV-1 Vaccine Design 2025 ·Current HIV Research ·Denise Guerra, (unknown), Tim Beaumont, Mathieu Claireaux, Marit J. van Gils	0
3	Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions 2024 ·Antiviral Research ·(unknown), David Falck, Manfred Wuhrer, Neeltje A. Kootstra, Marit J. van Gils, Steven W. de Taeye	3
4	Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies 2024 ·The EMBO Journal ·(unknown), (unknown), John L. van Hamme, Doris Wilflingseder, Godelieve de Bree, Maria Prins, Menno D. de Jong, Pythia T. Nieuwkerk, Marit J. van Gils, Neeltje A. Kootstra, Teunis B. H. Geijtenbeek	2
5	The Impact of First-Time SARS-CoV-2 Infection on Human Anelloviruses 2024 ·Viruses ·(unknown), (unknown), Martin Deijs, (unknown), A. H. Ayesha Lavell, Karlijn van der Straten, (unknown), Jacqueline van Rijswijk, Marit J. van Gils, Jonne J. Sikkens, Marije K. Bomers, Lia van der Hoek	3
6	Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing 2024 ·Communications Biology ·Steven W. de Taeye, (unknown), Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, (unknown), Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils	7
7	Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19 2023 ·Life Science Alliance ·Chiara E. Geyer, Hung‐Jen Chen, Alexander P. Bye, Xue D. Manz, Denise Guerra, Tom G. Caniels, Tom P. L. Bijl, Guillermo R. Griffith, Willianne Hoepel, Steven W. de Taeye, (unknown), Alexander P. J. Vlaar, (unknown), Gestur Vidarsson, Harm Jan Bogaard, Jurjan Aman, Jonathan M. Gibbins, Marit J. van Gils, Menno P.J. de Winther, Jeroen den Dunnen	6
8	Understanding repertoire sequencing data through a multiscale computational model of the germinal center 2023 ·npj Systems Biology and Applications ·(unknown), (unknown), (unknown), (unknown), Aldo Jongejan, (unknown), (unknown), Tom G. Caniels, Mathieu Claireaux, Anne Musters, Marit J. van Gils, María Rodríguez Martínez, Niek de Vries, Michael Meyer‐Hermann, Jeroen E. J. Guikema, Huub C. J. Hoefsloot, Antoine H. C. van Kampen	3
9	Next-generation bNAbs for HIV-1 cure strategies 2023 ·Antiviral Research ·(unknown), Yoann Aldon, Marit J. van Gils, Steven W. de Taeye	11
10	Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination 2022 ·Diagnostic Microbiology and Infectious Disease ·(unknown), (unknown), (unknown), (unknown), Patricia Sastre, Lia van der Hoek, Marit J. van Gils, Philip J. M. Brouwer, Rogier W. Sanders, Barbara Holzer, (unknown), Eduardo López‐Collazo, Patricia Muñóz, Paloma Rueda, Carmen Vela	4
11	Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns 2022 ·PLoS Pathogens ·Ilhan Tomris, Kim M. Bouwman, Youri Adolfs, Danny Noack, Roosmarijn van der Woude, Gius Kerster, Sander Herfst, Rogier W. Sanders, Marit J. van Gils, Geert‐Jan Boons, Bart L. Haagmans, R. Jeroen Pasterkamp, Barry Rockx, Robert P. de Vries	14
12	Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern 2022 ·Nature Communications ·(unknown), Albert Bondt, Max Hoek, Karlijn van der Straten, Tom G. Caniels, Meliawati Poniman, Dirk Eggink, Chantal Reusken, Godelieve J. de Bree, Rogier W. Sanders, Marit J. van Gils, Albert J. R. Heck	11
13	Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates 2021 ·PLoS Pathogens ·Jelle van Schooten, Marlies M. van Haaren, Hui Li, Laura E. McCoy, Colin Havenar‐Daughton, Christopher A. Cottrell, Judith A. Burger, Patricia van der Woude, Leanne C. Helgers, Ilhan Tomris, Celia C. LaBranche, David C. Montefiori, Andrew B. Ward, Dennis R. Burton, John P. Moore, Rogier W. Sanders, Shane Crotty, George M. Shaw, Marit J. van Gils	12
14	The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection 2021 ·PLoS Pathogens ·Tysheena P. Charles, Samantha L. Burton, Prabhu S. Arunachalam, Christopher A. Cottrell, Leigh M. Sewall, Venkata S. Bollimpelli, Sailaja Gangadhara, Antu Dey, Andrew B. Ward, George M. Shaw, Eric Hunter, Rama Rao Amara, Bali Pulendran, Marit J. van Gils, Cynthia A. Derdeyn	17
15	Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants breakdown → 2021 ·Science ·Meng Yuan, Deli Huang, Chang‐Chun D. Lee, Nicholas C. Wu, Abigail M. Jackson, Xueyong Zhu, Hejun Liu, Linghang Peng, Marit J. van Gils, Rogier W. Sanders, Dennis R. Burton, S. Momsen Reincke, Harald Prüß, Jakob Kreye, David Nemazee, Andrew B. Ward, Ian A. Wilson	196
16	A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern 2021 ·npj Vaccines ·Mitch Brinkkemper, Philip J. M. Brouwer, Pauline Maisonnasse, Marloes Grobben, Tom G. Caniels, Meliawati Poniman, Judith A. Burger, Ilja Bontjer, Melissa Oomen, Joey H. Bouhuijs, (unknown), Julien Villaudy, Yme U. van der Velden, Kwinten Sliepen, Marit J. van Gils, Roger Le Grand, Rogier W. Sanders	8
17	Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets 2021 ·Blood ·Alexander P. Bye, Willianne Hoepel, Joanne Mitchell, (unknown), Silvia Loureiro, Tanya Sage, Gestur Vidarsson, Jan Nouta, Manfred Wuhrer, (unknown), Marit J. van Gils, Neline Kriek, Nichola Cooper, Ian M. Jones, Jeroen den Dunnen, Jonathan M. Gibbins	67
18	An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain 2020 ·Cell Reports ·Nicholas C. Wu, Meng Yuan, Hejun Liu, Chang‐Chun D. Lee, Xueyong Zhu, Sandhya Bangaru, Jonathan L. Torres, Tom G. Caniels, Philip J. M. Brouwer, Marit J. van Gils, Rogier W. Sanders, Andrew B. Ward, Ian A. Wilson	95
19	A Recombinant HIV Envelope Trimer Selects for Quaternary Dependent Antibodies Targeting the Trimer Apex 2014 ·AIDS Research and Human Retroviruses ·Devin Sok, Marit J. van Gils, Matthias Pauthner, Karen L. Saye-Francisco, Jessica Hsueh, Bryan Briney, Jean‐Philippe Julien, Peter S. Lee, Yuanzi Hua, John P. Moore, Ian A. Wilson, Rogier W. Sanders, Dennis R. Burton	3
20	Evolution of Human Immunodeficiency Virus Type 1 in a Patient with Cross-Reactive Neutralizing Activity in Serum 2011 ·Journal of Virology ·Marit J. van Gils, Diana Edo-Matas, Emma J. Bowles, Judith A. Burger, Guillaume B. E. Stewart-Jones, Hanneke Schuitemaker	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact